Clinical Trials Directory

Trials / Completed

CompletedNCT04710940

Development and Feasibility Testing of DM-BOOST Intervention.

Development and Feasibility Testing of a Diabetes Mellitus Program Using Behavioral Economics to Optimize Outreach and Self-management Support With Technology.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
Daniel Amante · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

DM-BOOST uses clinical informatics tools to identify types of patients with gaps in diabetes care and deploy tailored, proactive outreach methods rooted in behavioral economics to nudge them towards increased engagement with diabetes self-management training and leverage patient-facing technologies to enhance longitudinal patient self-management support.

Detailed description

In DM-BOOST, the Principal investigator will deploy a mixed-methods, patient-centered approach to intervention development and initiate a multiphase optimization strategy (MOST) to learn how to maximize patient engagement and support of self-management training. In this pilot, study team will complete the first phase (Preparation), and initiate feasibility piloting of the second phase (Optimization). Completion of optimization and MOST's final phase (Evaluation), will occur in a subsequent project. In the preparation phase, Principal investigator will first analyze EHR and claims data in the UMCCTS data lake to identify sociodemographic characteristics associated with gaps in diabetes care to develop patient persona archetypes (Aim 1). Next, Principal investigator will selectively recruit patients of identified persona types as consultants, elicit stakeholder feedback during community engagement studios and conduct usability testing to iteratively design the intervention (Aim 2). Study team will then conduct a feasibility pilot (Aim 3) to assess user experience of the intervention implementation and collect exploratory outcome data to be used to inform a subsequent, complete optimization trial.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDiabetes BOOSTParticipants will receive supportive care using technology for DSMT in addition to usual care.
BEHAVIORALUsual CareParticipants will receive usual care for DSMT.

Timeline

Start date
2021-01-13
Primary completion
2022-11-01
Completion
2024-01-01
First posted
2021-01-15
Last updated
2024-02-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04710940. Inclusion in this directory is not an endorsement.